Summary* \9 N7 l6 q7 @9 m5 m9 k4 \: N

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt and will significantly affect the Sartans market in 2020.

COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.

The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyses the impact of Coronavirus COVID-19 on the Sartans industry.

Based on our recent survey, we have several different scenarios about the Sartans YoY growth rate for 2020. The probable scenario is expected to grow by a -3.4% in 2020 and the revenue will be US$ 25.0 billion in 2020 from US$ 25.9 billion in 2019. The market size of Sartans will reach US$ 27.2 billion in 2026, with a CAGR of 1.2% from 2020 to 2026.

[url=]Figure 1.   Global Sartans Market Size (Value), (US$ Billion), 2015 VS 2020 VS 2026[/url]

Source: Secondary Sources, Expert Interviews and QYResearch, 2020

Figure 2.   Global Sartans Revenue 2015-2026 (US$ Billion)

Source: Secondary Sources, Expert Interviews and QYResearch, 2020

Figure 3.   China Sartans Revenue 2015-2026 (US$ Billion)

Source: Secondary Sources, Expert Interviews and QYResearch, 2020

Figure 4.   Sartans Market Share Comparison: China Vs Global Other

Source: Secondary Sources, Expert Interviews and QYResearch, 2020

Sartans are the latest generation of antihypertensive drugs, which have good antihypertensive effect and drug tolerance, less adverse reactions, and have protective effect on target organs, so they are widely used in clinic. There are more than 1 billion patients with hypertension in the world. Long term treatment drives the demand for Sartans and intermediates. Due to the shortage of key intermediates, the tightening of environmental protection and the incident of Sartan impurities, the supply of Sartan products is in short supply and the price continues to rise.

The Sartans can be divided into five categories: Valsartan, Irbesartan, Telmisartan, Losartan and Others. Accordingly, the global market size of Valsartan, Irbesartan, Telmisartan, Losartan and Others will reach US $ xx billion, US $ xx billion, US $ xx billion, US $ xx billion, and US $ xx billion in 2019, respectively, which are increased compared to 2018 xx%, xx%, xx%, xx% and xx%. Valsartan takes a big amount of market with xx%.

Figure 5.   Global Sartans Market Structure by Type in 2015 & 2019

Source: Secondary Sources, Expert Interviews and QYResearch, 2020

Valsartan

Valsartan, sold under the trade name Diovan among others, is a medication used to treat high blood pressure, heart failure, and diabetic kidney disease. It is a reasonable initial treatment for high blood pressure. It is taken by mouth. Versions are available as the combination valsartan/hydrochlorothiazide, valsartan/amlodipine, valsartan/amlodipine/hydrochlorothiazide, or valsartan/sacubitril.

Irbesartan

Irbesartan, sold under the brand name Avapro among others, is a medication used to treat high blood pressure, heart failure, and diabetic kidney disease. It is a reasonable initial treatment for high blood pressure. It is taken by mouth. Versions are available as the combination irbesartan/hydrochlorothiazide.

Telmisartan

Telmisartan, sold under the trade name Micardis among others, is a medication used to treat high blood pressure, heart failure, and diabetic kidney disease. It is a reasonable initial treatment for high blood pressure. It is taken by mouth. Versions are available as the combination telmisartan/hydrochlorothiazide and telmisartan/amlodipine.

Losartan

Losartan, sold under the trade name Cozaar among others, is a medication mainly used to treat high blood pressure. It is also used for diabetic kidney disease, heart failure, and left ventricular enlargement. It is taken by mouth. It may be used alone or in addition to other blood pressure medication. Up to six weeks may be required for the full effects to occur.

Others

The other sartans contain Azilsartan, Olmesartan, Candesartan, etc.

From the perspective of application, Sartans can be divided into three main categories: Anti-Hypertension, Anti-Viral and Others. Accordingly, the global market size of Anti-Hypertension, Anti-Viral and Others will reach US $ xx billion, US $ xx billion, and US $ xx billion in 2019, respectively, which are increased compared to 2018 xx%, xx% and xx%. Anti-Hypertension takes a big amount of market with xx%.

Figure 6.   Global Sartans Market Structure by Application in 2015 & 2019

Source: Secondary Sources, Expert Interviews and QYResearch, 2020

Anti-Hypertension

Hypertension is one of the most common chronic diseases, and it is also the main risk factor to induce various cardiovascular and cerebrovascular diseases. There are more than 1 billion hypertensive patients in the world, and about 270 million hypertensive adults in China. The treatment of chronic hypertension requires long-term medication, and the huge patient base and long-term treatment demand drive the continuous expansion of the market of antihypertensive drug raw materials and preparations.

Figure 7.   Global Sartans Revenue in Anti- Hypertension 2015-2026 (US$ Billion)

Source: Secondary Sources, Expert Interviews and QYResearch, 2020

Anti-Viral

Antiviral drugs are a class of medication used specifically for treating viral infections rather than bacterial ones. Sartans are also used in the antiviral field, among which the more widely used is the treatment of AIDS.

Others

Other applications of Sartans are Anti-Asthma, Anti-Cardiovascular, Anti-Kidney, etc.

Major manufacturers

Table 1.   Major manufacturers and Products Offered

Source: Secondary Sources, Expert Interviews and QYResearch, 2020

Table 2.   Major manufacturers in China and products analysis

The research report studies the Sartans market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.Source: Secondary Sources, Expert Interviews and QYResearch, 2020

Global Sartans market: Drivers and Restraints

This section covers the various factors driving the global Sartans market. To understand the growth of the market it is important to analyze the various drivers present the market. It provides data by revenue and volume of different regions and their respective manufacturers. This data will elaborate on the market share occupied by them, predict their revenue concerning strategies, and how they will grow in the future. After explaining the drivers, the report further evaluates the new opportunities and current trends in the market.

Market restraints are factors hampering market growth. Studying these factors is equally pivotal as they help a reader need understand the weaknesses of the market.

Global Sartans market: Segment Analysis

The global Sartans market is split into two segments, type, and application. The product type briefs on the various types of products available in the market. The report also provides data for each product type by revenue and sales for the forecast time period. It covers the price of each type of product. The other segment on the report, application, explains the various uses of the product and end-users. In the report, the researchers have also provided sales according to the consumption of the product.

Global Sartans market: Regional Analysis

The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2015 to 2020. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.

Global Sartans market: Key Players

The report lists the major manufacturers in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.

By the product type, the market is primarily split into

Valsartan

Telmisartan

Losartan

Irbesartan

Azilsartan

Olmesartan

By the end users/application, this report covers the following segments

Hypertension

Cardiovascular Diseases

Kidney Diseases

Other

Competitive Landscape:

The report provides a list of all the key players in the Sartans market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product development, research, and development, and also provides revenue shares, company overview, and recent company developments to remain competitive in the market.

The Sartans key manufacturers in this market include:

Pfizer

Novartis

Merck

Astra Zeneca

Jhonson and Johnson

Eli Lilly

Sanofi

Bristol-Myers Squibb

Bayer

GSK

Teva Pharmaceutical

for more information

please go https://www.qyresearch.com/index ... obal-sartans-market

and you can go https://www.qyresearch.comto know more and more

if you need any help you can contact

qifeifei@qyresearch.com / telephone number ：18910840196

00861082945717

QY Research support best market reports for you.